AbbVie xStock is projected to rise to $309.91 by 2027, a +21% move from its current price of $255.46. ABBVX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 28/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 25 | $249.48 | $255.56 | $261.78 | +0.04% |
| Jul 26 | $247.10 | $255.65 | $264.50 | +0.08% |
| Jul 27 | $245.32 | $255.75 | $266.63 | +0.11% |
| Jul 28 | $243.83 | $255.85 | $268.45 | +0.15% |
| Jul 29 | $242.54 | $255.94 | $270.08 | +0.19% |
| Jul 30 | $241.39 | $256.04 | $271.58 | +0.23% |
| Jul 31 | $240.35 | $256.14 | $272.96 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $240.35 | $256.14 | $272.96 | +0.26% |
| Week 2 | $234.71 | $256.81 | $281.00 | +0.53% |
| Week 3 | $230.62 | $257.49 | $287.50 | +0.80% |
| Week 4 | $227.33 | $258.18 | $293.21 | +1.06% |
| Week 5 | $224.53 | $258.86 | $298.44 | +1.33% |
| Week 6 | $222.09 | $259.54 | $303.32 | +1.60% |
| Week 7 | $219.91 | $260.23 | $307.94 | +1.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AbbVie xStock ABBVX is a tokenized stock that represents a stake in AbbVie. It is backed 1:1 by the underlying asset and provides a legal claim to the stock value. xStocks are designed to be composable with DeFi protocols and are compliant with EU regulations, making them accessible to non-US users.
They enable easy access to 57 US Stocks and ETFs through top centralized and decentralized exchanges and can be integrated with other DeFi protocols like any other token.
ABBVX is currently trading at $255.46.
A major floor 24.4% below — a decisive break under it would weaken the trend.
The nearest floor, 18.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 12.4% above — clearing it would confirm fresh momentum.
Key ABBVX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABBVX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $254.68 | Buy | $252.55 | Buy |
| MA 10 | $244.00 | Buy | $245.66 | Buy |
| MA 20 | $231.66 | Buy | $236.39 | Buy |
| MA 50 | $221.18 | Buy | $225.23 | Buy |
| MA 100 | $215.05 | Buy | $220.73 | Buy |
| MA 200 | $220.60 | Buy | $219.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 77.18 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 118.39 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 3.05 | Buy |
| ROC (12) | 15.84 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.47 | Buy |
| Awesome (5,34) | 29.17 | Buy |
| Ultimate (7,14,28) | 88.50 | Sell |
| Momentum (10) | 34.95 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 260.37 | Sell |
| ADX (14) | 27.94 | Buy |
| ATR (14) | 3.32 | Info |
It has a market cap of $251.66K and a rank of 4316.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $195.03 | $255.46 | $354.96 | 0% | Neutral | |
| $247.69 | $309.91 | $409.63 | +21% | Bullish | |
| $464.08 | $596.02 | $815.87 | +133% | Bullish | |
| $776.86 | $1,019.60 | $1,434.61 | +299% | Bullish | |
| $778.46 | $1,041.45 | $1,499.74 | +308% | Bullish | |
| $874.04 | $1,189.87 | $1,748.59 | +366% | Bullish | |
| $1,799.69 | $2,490.06 | $3,726.57 | +875% | Bullish | |
| $1,844.68 | $2,591.42 | $3,942.86 | +914% | Bullish | |
| $2,066.16 | $2,944.77 | $4,549.15 | +10.5x | Bullish | |
| $2,688.30 | $3,884.72 | $6,086.61 | +14.2x | Bullish | |
| $7,503.97 | $11,542.58 | $19,190.70 | +44.2x | Bullish | |
| $20,493.16 | $35,078.88 | $63,606.85 | +136.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $195.03 | $255.46 | $331.50 | +0.00% |
| August 2026 | $228.05 | $269.48 | $327.23 | +5.49% |
| September 2026 | $222.38 | $264.41 | $324.22 | -1.88% |
| October 2026 | $245.28 | $293.22 | $362.57 | +10.89% |
| November 2026 | $255.49 | $306.84 | $382.13 | +4.65% |
| December 2026 | $234.74 | $283.15 | $354.96 | -7.72% |
Click any year to see its month-by-month ABBVX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ABBVX price prediction for 2026 points to an average of $255.46 (low $195.03, high $354.96) — a potential gain of 0% on today's $255.46. Price action looks broadly range-bound.
In 2027, ABBVX is projected to trade between $247.69 and $409.63, averaging $309.91 — a potential gain of +21% from today's $255.46. That is up +21% on the projected 2026 average. Buyers look set to stay in control over this stretch.
AbbVie xStock's 2028 outlook centres on $596.02, within a $464.08 to $815.87 range. That is up +92% on the projected 2027 average. That marks a +133% change versus current levels. Momentum favours further upside here.
By 2029, ABBVX could reach as high as $1,434.61, with a base case around $1,019.60 and support toward $776.86 — roughly +299% from $255.46. Buyers look set to stay in control over this stretch.
Expect ABBVX to range from $778.46 to $1,499.74 through 2030. The $1,041.45 average target implies a +308% move from current prices. That is up +2% on the projected 2029 average. Momentum favours further upside here.
The ABBVX price prediction for 2031 points to an average of $1,189.87 (low $874.04, high $1,748.59) — a potential gain of +366% on today's $255.46. Buyers look set to stay in control over this stretch.
In 2032, ABBVX is projected to trade between $1,799.69 and $3,726.57, averaging $2,490.06 — a potential gain of +875% from today's $255.46. That is up +109% on the projected 2031 average. Momentum favours further upside here.
AbbVie xStock's 2033 outlook centres on $2,591.42, within a $1,844.68 to $3,942.86 range. That is up +4% on the projected 2032 average. That marks a +914% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ABBVX could reach as high as $4,549.15, with a base case around $2,944.77 and support toward $2,066.16 — roughly +10.5x from $255.46. Momentum favours further upside here.
Expect ABBVX to range from $2,688.30 to $6,086.61 through 2035. The $3,884.72 average target implies a +14.2x move from current prices. That is up +32% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ABBVX price prediction for 2040 points to an average of $11,542.58 (low $7,503.97, high $19,190.70) — a potential gain of +44.2x on today's $255.46. Momentum favours further upside here.
In 2050, ABBVX is projected to trade between $20,493.16 and $63,606.85, averaging $35,078.88 — a potential gain of +136.3x from today's $255.46. That is up +204% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABBVX today (≈ 3.914507 ABBVX) could be worth
$137,316.53
+$136,316.53 (+13632%) by 2050 · US Dollar
Based on the average projected ABBVX price of $35,078.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABBVXwould be worth at today's price.
$1,000 invested in ABBVX on Jul 29, 2025 (≈ 5.206954 ABBVX) would be worth
$1,330.17
+$330.17 (+33.0%) today · 1.33× · US Dollar
Based on a ABBVX entry price of $192.05 vs. today's $255.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $235.98 | $1,082.55 | +8.3% |
| 1 month ago | $217.43 | $1,174.91 | +17.5% |
| 3 months ago | $216.22 | $1,181.51 | +18.2% |
| 6 months ago | $229.35 | $1,113.83 | +11.4% |
| All time ago | $192.05 | $1,330.17 | +33.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABBVX forecast.
Our base-case forecast reaches $510.00 around 2028.
Implied market cap at $510.00: $502.42K
The price outlook based on the provided forecast shows upside over time. The 2026 average price is $255.46 (neutral), and the trajectory climbs to $309.91 in 2027, $596.02 in 2028, and $1,019.60 in 2029, then to $1,041.45 in 2030. The forecast continues through 2035 with rising averages, and by 2040 the average is $11,542.58 and by 2050 it is $35,078.88.
Tap a question to reveal the answer.
2030 avg $1,041.45 with min $778.46, max $1,499.74 and ROI 307.7%; sentiment BULLISH.
Forecast shows upside with bullish sentiment in many years and an average price rising to $1,041.45 by 2030, but these are estimates and not guarantees.
Yes. The 2027 forecast lists an average of $309.91, indicating a path above $300 in that year.
Current price is $255.46 and market cap is $251.66K.
RSI14 is 80, sentiment BULLISH, SMA50 is $221.71, SMA200 is $220.73, support is $208.76, resistance is $255.83, and the 30-day range is $223.93 to $291.43.
AbbVie xStock Community Discussion
0Share your AbbVie xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.